News - Insulin Glargine [rDNA origin] Injection

Filter

Popular Filters

Merck and Samsung Bioepis expand collaboration to insulin glargine candidate

Merck and Samsung Bioepis expand collaboration to insulin glargine candidate

11-02-2014

US pharma giant Merck & Co and South Korea’s Samsung Bioepis have expanded their collaboration with…

BiosimilarsDiabetesInsulin Glargine [rDNA origin] InjectionLantusLicensingMerck & CoPharmaceuticalResearchSamsung BioepisSanofi

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top